As of 2024-12-11, the Intrinsic Value of Bristol-Myers Squibb Co (BMY) is 60.65 USD. This Bmy valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 58.12 USD, the upside of Bristol-Myers Squibb Co is 4.40%.

The range of the Intrinsic Value is 44.31 - 89.17 USD

	Range	Selected	Upside
a
DCF (Growth 5y)	44.31 - 89.17	60.65	4.4%
DCF (Growth 10y)	52.82 - 100.28	70.18	20.8%
DCF (EBITDA 5y)	30.79 - 45.12	37.05	-36.2%
DCF (EBITDA 10y)	41.77 - 60.08	49.76	-14.4%
Fair Value	-17.89 - -17.89	-17.89	-130.79%
P/E	(100.20) - 127.32	0.26	-99.6%
EV/EBITDA	60.35 - 120.57	80.15	37.9%
EPV	136.00 - 190.80	163.40	181.1%
DDM - Stable	(31.77) - (71.49)	(51.63)	-188.8%
DDM - Multi	39.50 - 70.84	50.88	-12.5%